ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Dimeric oxyberberine CT4-1 targets LINC02331 to induce cytotoxicity and inhibit chemoresistance via suppressing Wnt/β-catenin signaling in hepatocellular carcinoma

Lin, Xian; Chen, Jian; Li, Xin; Chen, Dong; Luo, Kaixuan; Deng, Yongxing; Yang, Dinghua*; Huang, Zunnan*; Tao, Cheng*广东医学院; 北京大学; 南方医科大学
Archives of Toxicology2023-6DOI: 10.1007/s00204-023-03501-8
2被引5阅读
引用收藏
分享

摘要

Hepatocellular carcinoma (HCC) is a type of cancer characterized by high recurrence rates. Overcoming chemoresistance can reduce HCC recurrence and improve patients' prognosis. This work aimed to identify HCC chemoresistance-associated long non-coding RNA (lncRNA) and find an effective drug targeting the identified lncRNA for ameliorating the chemoresistance. In this investigation, bioinformatics analysis based on The Cancer Genome Atlas revealed a new chemoresistance index and suggested LINC02331 as an HCC chemoresistance and patients' prognosis-associated lncRNA that served as an independent prognostic indicator. Moreover, LINC02331 promoted DNA damage repair, DNA replication, and epithelial-mesenchymal transition as well as attenuated cell cycle arrest and apoptosis through regulating Wnt/beta-catenin signaling, thus stimulating HCC resistance to cisplatin cytotoxicity, proliferation, and metastasis. Interestingly, we developed a novel oxidative coupling approach to synthesize a dimeric oxyberberine CT4-1, which exerted superior anti-HCC activities without obvious side effects measured by in vivo mice model and could downregulate LINC02331 mice model and could downregulate LINC02331 to mitigate LINC02331-induced HCC progression by suppressing Wnt/beta-catenin signaling. RNA sequencing analyses verified the involvement of CT4-1-affected differential expression genes in dysregulated pathways and processes, including Wnt, DNA damage repair, cell cycle, DNA replication, apoptosis, and cell adhesion molecules. Furthermore, CT4-1 was demonstrated to be an effective cytotoxic drug in ameliorating HCC patients' prognosis with a prediction model constructed based on RNA-sequencing data from CT4-1-treated cancer cells and public cancer database. In summary, HCC chemoresistance-associated LINC02331 independently predicted poor patients' prognosis and enhanced HCC progression by promoting resistance to cisplatin cytotoxicity, proliferation, and metastasis. Targeting LINC02331 by the dimeric oxyberberine CT4-1 that exhibited synergistic cytotoxicity with cisplatin could alleviate HCC progression and improve patients' prognosis. Our study identified LINC02331 as an alternative target and suggested CT4-1 as an effective cytotoxic drug in HCC treatment.

学科与关键词

关键词
Dimeric oxyberberineChemoresistanceCytotoxicityHepatocellular carcinomaLINC02331
相关
加载中…
  • Linc-ROR drive adriamycin resistance by targeting AP-2α/Wnt/β-catenin axis in hepatocellular carcinoma
    Shi, Chuan-Jian; Lv, Min-Yi; Deng, Li-Qiang; Zeng, Wei-Qiang; Fu, Wei-Ming*; Zhang, Jin-Fang*Cell Biology and Toxicology, 2023, 39(4): 1735-1752.被引 1
  • Cancer stemness-associated LINC02475 serves as a novel biomarker for diagnosis and prognosis prediction of hepatocellular carcinoma
    Lin, Xian; Luo, Lianxiang; Zou, Yujiao; Chen, Jian*Frontiers in Genetics, 2022, 13: 991936.被引 4
  • Targeting LINC01607 sensitizes hepatocellular carcinoma to Lenvatinib via suppressing mitophagy
    Zhang, Yuxin; Zhang, Yujie; Tao, Haisu; Zhu, Jinghan; Lu, Yuanxiang; Cheng, Fangling; Xiong, Yixiao; Liu, Junjie; Cai, Guangzhen; Zhang, Zhanguo*; Liang, Huifang*; Chen, Yifa*; Zhang, Wanguang*Cancer Letters, 2023, 576: 216405.被引 1
查看全部 →

发表信息

论文状态
公开发表
期刊
Archives of Toxicology
发表日期
2023-06
卷期
第 97 卷, 第 6 期
页码
1627-1647
DOI
10.1007/s00204-023-03501-8
语言
ENGLISH
成果收录
SCIE
资助标注
China Postdoctoral Science Foundation [2021T140468]; Guangdong Basic and Applied Basic Research Foundation [2021A1515111089, A2022042]; Key Discipline Con-struction Project of Guangdong Medical University [2021B1515140027]; Medical Scientific Research Foundation of Guangdong Province, China [4SG22004G]; Dongguan Social science and Technology Development (Key) Project [20221800905582]; Funds for Ph.D. researchers of Guangdong Medical University in 2022 [4SG22226G]

作者

  • L

    Lin, Xian (第一作者)

    guangdong med univ

  • C

    Chen, Jian

    peking univ

查看全部 9 位作者收起作者
  • L

    Li, Xin

    guangdong med univ

  • C

    Chen, Dong

    peking univ

  • L

    Luo, Kaixuan

    guangdong med univ

  • D

    Deng, Yongxing

    guangdong med univ

  • Y

    Yang, Dinghua (通讯)

    southern med univ

  • H

    Huang, Zunnan (通讯)

    guangdong med univ

  • T

    Tao, Cheng (通讯)

    guangdong med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417